Publications by authors named "Xihe Chen"

Background/purpose: Visible light (VL), a substantial component of solar radiation, contributes to skin photodamage, including hyperpigmentation and erythema. Tinted sunscreens have emerged as effective tools for mitigating VL-induced effects, yet challenges remain in their adoption and utilization. This review updates recent evidence on their clinical efficacy and explores obstacles constraining their broader recognition and utilization.

View Article and Find Full Text PDF

T cell receptor (TCR)-engineered T cell therapy is a promising potential treatment for solid tumors, with preliminary efficacy demonstrated in clinical trials. However, obtaining clinically effective TCR molecules remains a major challenge. We have developed a strategy for cloning tumor-specific TCRs from long-term surviving patients who have responded to immunotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • αvβ6 integrin is normally hard to detect in epithelial cells but is upregulated during wound healing and cancer, notably in certain carcinomas, though not previously in hepatocellular carcinoma (HCC).
  • TGF-β1 and lysophosphatidic acid (LPA) are shown to impact the progression of HCC and may regulate the expression of the Itgβ6 subunit.
  • The study establishes that Itgβ6 is expressed in HCC tissues and Hep-3B cells, and its expression is enhanced by TGF-β1 and LPA, revealing a regulatory region in the Itgβ6 gene promoter crucial for HCC development.
View Article and Find Full Text PDF

The integrin β6 (ITGB6) gene, which encodes the limiting subunit of the integrin αvβ6 heterodimer, plays an important role in wound healing and carcinogenesis. The mechanism underlying ITGB6 regulation, including the identification of DNA elements and cognate transcription factors responsible for basic transcription of human ITGB6 gene, remains unknown. This report describes the cloning and characterization of the human ITGB6 promoter.

View Article and Find Full Text PDF

Chemokine (CC motif) ligand-2 (CCL2) is a member of C-C chemokine superfamily that contributes to inflammatory and fibrotic process. Studies in patients and experimental animals provide compelling evidence that increased CCL2 expression plays an important role in the development of fibroproliferative lung disease. The up-regulated CCL2 expression in pulmonary fibrosis is also involved in the potent profibrotic effects that thrombin exerts during lung injury.

View Article and Find Full Text PDF